Sharma East India Hospitals & Medical Research Limited submitted its standalone unaudited financial results for the quarter and half year ended September 30, 2026 to BSE Limited in pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The board of directors approved the financial results at a meeting held on November 07, 2026, which commenced at 6:00 p.m. (IST) and concluded at 7:30 p.m. (IST). The statutory auditors, Gopal Sharma & Co., carried out a limited review of the financial results and issued a report stating that nothing came to their attention that causes them to believe the statement contains any material misstatement.
Financial Performance (Quarter Ended September 30, 2026)
- Revenue from Operations: ₹1,035.89 lakh (compared to ₹938.45 lakh in Q2 September 2025)
- Other Income: ₹4.55 lakh (compared to ₹5.00 lakh in Q2 September 2025)
- Total Revenue: ₹1,040.44 lakh (compared to ₹943.45 lakh in Q2 September 2025)
- Profit Before Tax: ₹35.46 lakh (compared to ₹45.61 lakh in Q2 September 2025)
- Total Tax Expense: ₹26.24 lakh (includes current tax/MAT of ₹12.36 lakh, taxation for earlier years of ₹(3.14) lakh, and deferred tax of ₹9.22 lakh)
- Profit for the Period: ₹26.24 lakh (compared to ₹31.78 lakh in Q2 September 2025)
- Earnings Per Share (Basic and Diluted): ₹0.80 (compared to ₹0.97 in Q2 September 2025)
Financial Performance (Half Year Ended September 30, 2026)
- Revenue from Operations: ₹2,112.36 lakh (compared to ₹1,885.82 lakh in H1 September 2025)
- Other Income: ₹8.30 lakh (compared to ₹9.00 lakh in H1 September 2025)
- Total Revenue: ₹2,120.66 lakh (compared to ₹1,894.82 lakh in H1 September 2025)
- Profit Before Tax: ₹70.62 lakh (compared to ₹88.59 lakh in H1 September 2025)
- Total Tax Expense: ₹52.26 lakh (includes current tax/MAT of ₹21.50 lakh, taxation for earlier years of ₹(3.14) lakh, and deferred tax of ₹18.36 lakh)
- Profit for the Period: ₹52.26 lakh (compared to ₹63.58 lakh in H1 September 2025)
- Earnings Per Share (Basic and Diluted): ₹1.59 (compared to ₹1.94 in H1 September 2025)
Balance Sheet Position (As at September 30, 2026)
- Total Assets: ₹3,695.90 lakh (compared to ₹3,291.82 lakh as at March 31, 2026)
- Non-Current Assets: ₹1,222.30 lakh (includes investments of ₹204.77 lakh)
- Current Assets: ₹2,473.60 lakh (includes inventories of ₹315.71 lakh, trade receivables of ₹1,552.33 lakh, and cash & cash equivalents of ₹29.25 lakh)
- Total Equity: ₹1,424.20 lakh (equity share capital of ₹415.75 lakh and other equity of ₹1,008.45 lakh)
- Non-Current Liabilities: ₹149.36 lakh (includes borrowings of ₹141.13 lakh)
- Current Liabilities: ₹2,122.34 lakh (includes borrowings of ₹671.48 lakh and trade payables of ₹543.67 lakh)
Cash Flow Statement (Half Year Ended September 30, 2026)
- Net Cash from Operating Activities: ₹(150.31) lakh
- Net Cash used in Investing Activities: ₹(10.96) lakh
- Net Cash from Financing Activities: ₹145.09 lakh
- Net decrease in cash and cash equivalents: ₹(16.18) lakh
- Cash and cash equivalents at beginning: ₹45.43 lakh
- Cash and cash equivalents at end: ₹29.25 lakh (includes cash in hand of ₹4.97 lakh and bank balances of ₹24.28 lakh)
Additional Information
- The company is not a Large Corporate as per SEBI circular dated November 26, 2018
- Figures for previous periods have been re-grouped/re-arranged and/or recast wherever necessary
- The financial results were prepared in accordance with Indian Accounting Standards (Ind AS)
- Paid-up equity share capital: ₹415.75 lakh (face value of ₹10 per share)